Catch us at an upcoming conference or tradeshow – or sign up for one of our own upcoming events and Benchtalk forums.
Antibody Engineering & Therapeutics Conference
December 10, 2019San Diego, CA
Benchling will be an exhibitor at the Antibody Engineering & Therapeutics Conference. This conference brings the latest antibody science, technologies and partners needed to accelerate next generation antibodies towards commercial success. Its scientific program designed by The Antibody Society, will cover content such as tumor-conditional immunotherapy, tissue specific delivery of antibodies, reverse translation: antibody engineering and clinical data, and bioinformatics and computational tools for antibody optimization and engineering.
Benchling’s presence at SLAS2020 will namely include a solutions spotlight presentation entitled “Announcing Benchling for Lab Automation: Digital Transformation for High-throughput Workflows” on January 27 at 11am at the Exhibition Theater. The presentation will introduce the new, vendor-agnostic Benchling for Lab Automation solution, which provides R&D teams a centralized environment to design, document and run 100s-1000s of samples with complete traceability across programs and teams. Visit also Benchling’s booth #151 to learn more.
Benchling will be sponsoring the FierceBiotech Executive Breakfast & Panel Discussions being held during 2020's J.P. Morgan Healthcare Conference. Attendees will have the opportunity to expand their knowledge on the biotech and healthcare industries, while enjoying the chance to network with peers and colleagues. The two panels this year include: Strategic Considerations for the Commercialization of Cell and Gene Therapies, and The Promise of AI: Can Artificial Intelligence and Machine Learning Really Transform R&D. View panelists and register through the link!
Benchling will be exhibiting at booth #516 and presenting in the Engineering Next-Generation Cancer Immunotherapies track on Monday January 20th at 12:30pm. The 19th annual PepTalk conference hosts over 1300 attendees from academia, biotech, and pharma backgrounds to hear from some of the most influential leaders in the biotherapeutics industry. Conference programs focus on Protein and Antibody Engineering & Development, Cell & Gene Therapies, and more.